Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00457912 · ClinicalTrials.gov registry record

Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy

A clinical trial, sponsored by Nationwide Children's Hospital.

Completed
Registry status
277
Enrollment target

NCT00457912 is a clinical trial that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 277 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00457912 has completed, sponsored by Nationwide Children's Hospital.

COMPLETED
Registry status
277 participants
Enrollment target

Study Summary

The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this study, the investigators will perform a muscle biopsy and DNA testing in an unlimited number of patients with clinically diagnosed LGMD. The genetic testing will be extended to the family of the study subject in order to better understand true genetic defect.

Trial Details

FieldValue
Enrollment Target 277 participants
Start Date 2005-06
Est. Completion 2018-01-01

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT00457912

The ClinicalTrials.gov registry entry for NCT00457912 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 277 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00457912 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00457912 about?

NCT00457912 is a clinical study titled "Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy". The objective of this study is to identify and maintain a registry of well-characterized limb-girdle muscular dystrophy (LGMD) patients. Patients seen as part of this study may be candidates for future treatment trials based on their defined genetic classification of LGMD. In the course of this stud...

What is the current status of trial NCT00457912?

This trial is currently completed. The enrollment target is 277 participants. The study started on 2005-06. Estimated completion is 2018-01-01.

Who is sponsoring clinical trial NCT00457912?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.